Sempra · SRE · FY2025 Q2 · Calendar Q3 2025

Sempra Maintains Guidance as Utilities and LNG Plans Advance

The supplied analysis supports a cautiously constructive operating thesis: maintained guidance and a confident management tone are paired with utility load growth, infrastructure investment and advancing LNG projects. The thesis depends on regulatory progress, transaction execution and delivery of the capital program.

Reported Before market openNYSEUtilities $51.24B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.89 Consensus $0.85
EPS surprise +5.2% Reported versus consensus
Reported revenue $3.00B Consensus $3.10B
Revenue surprise -3.1% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +1.8% Event window
SPY move -0.1% Same window
Abnormal move +1.9% Stock minus SPY
Volume 1.8× Versus trailing sessions
Subsequent drift -1.8% Up to 20 sessions
SRESPY benchmark

Ask FN2 about SRE FY2025 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Relative to the prior-quarter analysis, the supplied current analysis emphasizes further progress toward the KKR equity sale and Ecogas transaction, advancing ECA LNG and Cimarron Wind, and a path toward Port Arthur LNG Phase 2 final investment decision. It also highlights Oncor's expanding Texas capital plan and regulatory developments around UTM.

Guidance delta

Maintained: the supplied analysis says Sempra reaffirmed its 2025 and 2026 EPS guidance.

Key takeaways

  • Sempra is emphasizing a utility-centric strategy, with capital concentrated in U.S. utilities and especially Texas.
  • Management highlighted progress on capital recycling, including the KKR equity-sale process and Ecogas transaction.
  • LNG, wind and transmission projects are advancing, while Port Arthur LNG Phase 2 moves toward a final investment decision.
  • Regulatory developments and customer-affordability measures remain central to the outlook.
  • The main watchpoints are transaction timing, regulatory approvals and execution across large infrastructure projects.

Management priorities

  • Advance the KKR equity sale and Ecogas transaction.
  • Expand Oncor's Texas capital plan and pursue UTM-related regulatory progress.
  • Bring ECA LNG and Cimarron Wind into commercial operation in 2026.
  • Continue Port Arthur LNG Phase 2 toward final investment decision and construction.
  • Execute affordability and wildfire-hardening initiatives in California.

Follow SRE with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
SRE EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $1.34 Q1 '24 actual $1.34, match Q2 '24 estimate $0.94 Q2 '24 actual $0.89, miss Q3 '24 estimate $1.05 Q3 '24 actual $0.89, miss Q2 '25 estimate $0.85 Q2 '25 actual $0.89, beat Q3 '25 estimate $0.91 Q3 '25 actual $1.11, beat Q4 '25 estimate $1.24 Q4 '25 actual $1.28, beat Q1 '26 estimate $1.51 Q1 '26 actual $1.51, match Q2 '26 estimate $1.01 Q2 '26 actual $1.16, beat Q3 '26 estimate $1.09 Q4 '26 estimate $1.44 Q1 '27 estimate $1.60
Show 1 more >

Analyst Consensus ?

ConsensusBuy24 ratings
Bullish2083.3%
Neutral416.7%
Bearish00.0%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$79.97Current
$36.25Low
$86.26Average
$118High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 6, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Morgan Stanley Overweight OverweightMaintainSep 18, 2026
Truist Securities Buy BuyMaintainSep 3, 2026
JP Morgan Overweight OverweightMaintainSep 2, 2026
Jefferies Buy HoldUpgradeSep 1, 2026
Mizuho Neutral OutperformDowngradeAug 31, 2026
BMO Capital Outperform OutperformMaintainJul 22, 2026
Barclays Overweight OverweightMaintainJul 9, 2026
Wells Fargo Overweight OverweightMaintainMar 23, 2026
UBS Neutral NeutralMaintainMar 6, 2026
Evercore ISI Group Outperform OutperformMaintainMar 5, 2026
Argus Research Buy HoldUpgradeMar 4, 2026
Citigroup Neutral NeutralMaintainNov 24, 2025
Goldman Sachs Buy NeutralUpgradeNov 14, 2025
Guggenheim Buy BuyMaintainFeb 26, 2025
Ladenburg Thalmann Buy BuyMaintainMay 29, 2024
RBC Capital Outperform OutperformMaintainMar 6, 2024
B of A Securities Buy BuyMaintainMar 28, 2023
Credit Suisse Outperform OutperformMaintainApr 26, 2022
Keybanc Sector Weight OverweightDowngradeMar 7, 2022
Seaport Global Neutral BuyDowngradeApr 7, 2021
CFRA Strong Buy BuyUpgradeMar 18, 2020
Bank of America Buy NeutralUpgradeOct 11, 2018
Argus Buy HoldUpgradeMay 21, 2018
ISI Group Buy NeutralUpgradeJun 9, 2014
Bank oferica Buy BuyMaintainMay 4, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $79.97. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
ScotiabankAnalyst unavailable$83$76.9 +3.8%Sep 29, 2026
Truist FinancialRichard Sunderland$96$83.8 +20.0%Sep 3, 2026
JefferiesAnalyst unavailable$97$81.7 +21.3%Sep 1, 2026
Mizuho SecuritiesAnalyst unavailable$84$84.32 +5.0%Aug 31, 2026
Truist FinancialAnalyst unavailable$100$86.53 +25.0%Aug 13, 2026
Morgan StanleyDavid Arcaro$108$92.88 +35.1%Jul 22, 2026
BMO CapitalAnalyst unavailable$102$92.79 +27.5%Jul 22, 2026
JefferiesAnalyst unavailable$101$92.78 +26.3%Jul 16, 2026
BarclaysAnalyst unavailable$103$95.15 +28.8%Jul 9, 2026
Morgan StanleyAnalyst unavailable$105$91.9 +31.3%Jun 24, 2026
Truist FinancialAnalyst unavailable$104$90.43 +30.0%May 18, 2026
Morgan StanleyAnalyst unavailable$104$93.27 +30.0%Apr 21, 2026
Wells FargoAnalyst unavailable$118$93.38 +47.6%Apr 21, 2026
Truist FinancialRichard Sunderland$108$93.38 +35.1%Apr 20, 2026
BarclaysAnalyst unavailable$105$96.16 +31.3%Apr 15, 2026
Morgan StanleyAnalyst unavailable$101$93.34 +26.3%Feb 20, 2026
BarclaysNicholas Campanella$95$86.22 +18.8%Feb 3, 2026
Morgan StanleyDavid Arcaro$97$86.8 +21.3%Feb 2, 2026
UBSAnalyst unavailable$100$85.98 +25.0%Jan 22, 2026
UBSAnalyst unavailable$92$85.98 +15.0%Jan 22, 2026
BarclaysNicholas Campanella$97$85.98 +21.3%Jan 22, 2026
Morgan StanleyAnalyst unavailable$95$84.89 +18.8%Jan 21, 2026
Wells FargoShahriar Pourreza$112$92.55 +40.1%Jan 20, 2026
UBSAnalyst unavailable$96$87.91 +20.0%Dec 17, 2025
Morgan StanleyAnalyst unavailable$91$88.57 +13.8%Dec 16, 2025
Morgan StanleyAnalyst unavailable$98$91.12 +22.5%Nov 20, 2025
Wells FargoAnalyst unavailable$115$93.17 +43.8%Oct 27, 2025
Morgan StanleyDavid Arcaro$99$91.88 +23.8%Oct 22, 2025
BMO CapitalJames Thalacker$99$92.29 +23.8%Oct 22, 2025
JefferiesAnalyst unavailable$89$92.29 +11.3%Oct 22, 2025
BTIGAnalyst unavailable$106$92.29 +32.5%Oct 21, 2025
BarclaysAnalyst unavailable$101$91.29 +26.3%Oct 20, 2025
Evercore ISIAnalyst unavailable$105$92.46 +31.3%Oct 6, 2025
BarclaysAnalyst unavailable$80$81.72 +0.0%Aug 26, 2025
BarclaysNicholas Campanella$71$74.9 -11.2%Jul 10, 2025
Morgan StanleyDavid Arcaro$87$76.75 +8.8%May 22, 2025
Morgan StanleyDavid Arcaro$89$73.31 +11.3%Apr 23, 2025
JefferiesJulien Dumoulin-Smith$75$69.73 -6.2%Apr 14, 2025
Morgan StanleyAnalyst unavailable$86$70 +7.5%Mar 20, 2025
JefferiesJulian Dumoulin-Smith$98$85.96 +22.5%Oct 24, 2024
BMO CapitalJames Thalacker$96$84.83 +20.0%Oct 21, 2024
Mizuho SecuritiesAnthony Crowdell$93$84.83 +16.3%Oct 21, 2024
BarclaysNicholas Campanella$89$83.63 +11.3%Oct 1, 2024
Morgan StanleyDavid Arcaro$85$83.02 +6.3%Sep 25, 2024
BMO CapitalJames Thalacker$93$81.37 +16.3%Sep 12, 2024
Morgan StanleyDavid Arcaro$80$81.67 +0.0%Aug 23, 2024
Mizuho SecuritiesAnthony Crowdell$88$79.96 +10.0%Aug 16, 2024
BarclaysNicholas Campanella$87$78.99 +8.8%Aug 13, 2024
BMO CapitalJames Thalacker$90$77.57 +12.5%Aug 9, 2024
Mizuho SecuritiesAnthony Crowdell$86$77.67 +7.5%May 17, 2024
Mizuho SecuritiesAnthony Crowdell$79$70.97 -1.2%Apr 4, 2024
BarclaysEric Beaumont$77$71.96 -3.7%Feb 22, 2024
Raymond JamesJames Thalacker$84$74.8 +5.0%Jan 11, 2024
BMO CapitalJames Thalacker$84$74.84 +5.0%Jan 11, 2024
J.P. MorganChristopher Turnure$86$76.01 +7.5%Jan 4, 2024
BarclaysEric Beaumont$76$70.12 -5.0%Nov 1, 2023
BarclaysEric Beaumont$156$70.3 +95.1%Oct 19, 2023
CitigroupAnalyst unavailable$42.75$41.21 -46.5%Apr 28, 2022
Credit SuisseAnalyst unavailable$45$41.34 -43.7%Apr 26, 2022
Morgan StanleyAnalyst unavailable$42$43.12 -47.5%Apr 20, 2022
RBC CapitalShelby Tucker$39.5$32.68 -50.6%Jan 24, 2022
Vertical ResearchJonathan Arnold$39.5$34.18 -50.6%Jan 10, 2022
Wells FargoSarah Akers$36.25$30.9 -54.7%Nov 8, 2021
Show less

Track every rating change on SRE the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Sempra, an energy holding company founded in 1998 and headquartered in San Diego, California, conducts its operations both domestically and internationally. The firm adopted its current name in July 2021, having previously been known as Sempra Energy. Through its San Diego Gas & Electric Company division, Sempra delivers electricity to approximately 3.6 million individuals and natural gas to roughly 3.3 million individuals across a 4,100 square mile service area.…

Historical context

All SRE earnings

Latest beats and misses

Who reports next

Get the SRE recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-10-05T20:00:45.076128+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-05T20:00:45.071990+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-05. For educational purposes only; not investment advice.